Anthropic Drug Manufacturers - Specialty and Generic Profile - TipRanks - Anthropic Analyst
4 Followers
Anthropic Drug Manufacturers - Specialty and Generic TipRanks - Anthropic
AI Analyst
Success Rate
52 out of 102 ratings made a profit
Average Return
+1.60%
Average return per rating
Time Frame
Compare to
Copying Anthropic Drug Manufacturers - Specialty and Generic's trades since 2025 and holding each position for 1 Year would result in 50.98% of your transactions generating a profit, with an average return of 1.6% per rating.
Stock Rating Distribution
66.44% Hold
25.33% Sell
8.23% Buy
Distribution of Anthropic Drug Manufacturers - Specialty and Generic's ratings
Additional Information
Main Sector:Healthcare
Geo Coverage:
Best Rating
The most profitable rating made by Anthropic Drug Manufacturers - Specialty and Generic
Anthropic Drug Manufacturers - Specialty and Generic's Stock Coverage
Ayr Wellness
Oct 22, 2025
Sell
Initiated
―
1Ratings
―
0.00%
Next Science Ltd
Oct 22, 2025
Hold
Initiated
$0.11
(10716.05% Upside)
1Ratings
―
0.00%
Kissei Pharmaceutical Co
Nov 28, 2025
Buy
Upgraded
¥5,237.00
(19.84% Upside)
2Ratings
-12.30%
Cannabist Company Holdings
Dec 11, 2025
Hold
Reiterated
C$0.56
(1491.43% Upside)
3Ratings
―
0.00%
Dynavax
Dec 31, 2025
Hold
Reiterated
$16.50
(6.45% Upside)
5Ratings
―
0.00%
Percheron Therapeutics
Jan 04, 2026
Sell
Initiated
<AU$0.01
(100.00% Upside)
1Ratings
―
0.00%
Intercure
Jan 08, 2026
Sell
Reiterated
285.00
(13.10% Upside)
2Ratings
+38.70%
Cann Group
Jan 10, 2026
Sell
Downgraded
AU$0.01
(100.00% Upside)
5Ratings
―
0.00%
Avadel Pharmaceuticals
Jan 13, 2026
Buy
Reiterated
$24.00
(10.91% Upside)
7Ratings
―
0.00%
Sweet Earth Holdings
Jan 13, 2026
Sell
Initiated
C$0.49
(-4.90% Downside)
1Ratings
0.00%
List of latest recommendations made by Anthropic Drug Manufacturers - Specialty and Generic. Click to expand and see Anthropic Drug Manufacturers - Specialty and Generic's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >About Analyst Ratings
About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.
Anthropic Drug Manufacturers - Specialty and Generic activity FAQ
What is the performance of Anthropic Drug Manufacturers - Specialty and Generic's recommendations?
The percentage of profitable recommendations made by Anthropic Drug Manufacturers - Specialty and Generic is 51%, and the average return per transaction is 1.60%.
What stocks does Anthropic Drug Manufacturers - Specialty and Generic cover?
What was Anthropic Drug Manufacturers - Specialty and Generic's most profitable rating?
Anthropic Drug Manufacturers - Specialty and Generic’s most profitable ratings was a sell on IMCC stock on Oct 22, 2025 - Today. The return on the trade was +86.20%.
Where can I see a list of stock analyst ratings?
You can see a list of daily stock analyst ratings here.
What are the most recommended stocks by analysts?
You can see a list of the most recommended stocks by analysts here